Muscle Volumizer, 30 Servings (IDS)
Product Info ► Label Info ► Articles
Muscle Volumizer [Product Information]: |
Introducing...Muscle Volumizer!
Muscle Volumizer combines both Titrated Creatine and Di Creatine Malate using the blood vessel dilating power of AKG as a pump inducing rapid delivery system. This powerful combination yields both fast acting strength results and lean body weight increases with dramatically improved recovery.
Muscle Volumizer uses 50% more AKG than before to yield muscle pumps and vascularity without bloating. Pump inducing AKG increases muscle size, and recovery while maintaining your lean shredded look. Now you can take advantage of a full round muscles from creatine use, but have deep cuts at the same time!
Muscle Volumizer Highlights:
- Faster, More Effective Delivery of Creatine Titrate to Muscle Cells
- Increased Nitrogen Retention for Anabolic Growth
- Fuller, Longer Lasting Pumps
- Increased Muscle Strength & Vascularity
- Faster Recovery Times
- Increased Oxygen for Endurance
|
| Muscle Volumizer [Supplement Facts]: |
| 30 Servings |
|
| Serving Size 1 Scoops (22 g) |
| Servings Per Container 30 |
|
| Calories |
48 |
|
| Amount Per Serving |
% Daily Value* |
|
| Total Carbohydrates |
12 g |
2% |
| Sugar |
11 g |
4% |
| Fiber |
0 g |
|
| Titrated Creatine™ |
4 g |
* |
| L-Arginine Alpha-Ketoglutarate |
4.5 g |
* |
| L-Taurine |
1 g |
* |
|
| * Daily Values not established |
|
|
| Other Ingredients |
| Dextrose , Natural And Artificial Flavors , Acesulfame Potassium , Citric Acid , Sucralose , And FD&C Red #40 |
|
Directions: Mix 1 scoop of Muscle Volumizer with 10-12 oz. of water. Take 1 serving in the morning or following workout.
Warnings: Consult your physician before using.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
|
Buy Muscle Volumizer today!
Save more on Muscle Volumizer with our instant coupons and quantity discounts! |
|  | ► Related / You May Also Like: | | | | | | | | | |
|
|
